SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Greene JA, Watkins ES. New Engl. J. Med. 2015; 373(12): 1087-1089.

Affiliation

From the Division of General Internal Medicine and the Department of the History of Medicine, Johns Hopkins University School of Medicine, Baltimore (J.A.G.); and the Department of Anthropology, History and Social Medicine, University of California, San Francisco, School of Medicine, San Francisco (E.S.W.).

Copyright

(Copyright © 2015, Massachusetts Medical Society)

DOI

10.1056/NEJMp1507924

PMID

26287749

Abstract

Aside from New Zealand, the United States is the only country with a strong pharmaceutical regulatory infrastructure that allows direct-to-consumer advertising (DTCA) of prescription drugs in print, broadcast, and electronic media. U.S. consumers are accustomed to full-page ads in newspapers and magazines detailing a drug's benefits - followed by another page of fine print in which its contraindications, risks, and side effects are spelled out in minute detail and equally minute print. That may soon change, however, as the Food and Drug Administration (FDA) moves to enact new regulations regarding risk communication in DTCA. Earlier this year, the FDA sought. . .


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print